Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-20

Clinical Trial Update: Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating gemcitabine plus radiation therapy for pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemzar (gemcitabine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED